Recurrence and mortality prognostic factors in childhood adrenocortical tumors: Analysis from the Brazilian National Institute of Cancer experience

References

• Mansmann G, Lau J, Balk E, et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev. 2004;25:309–340.
   PubMed Web of Science ®Google Scholar
• Kebebew E, Reiff E, Duh QY, et al. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg. 2006;30:872–878.
   PubMed Web of Science ®Google Scholar
• Zancanella P, Pianovski MA, Oliveira BH, et al. Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression. J Pediatr Hematol Oncol. 2006;28:513–524.
   PubMed Web of Science ®Google Scholar
• Ribeiro RC, Sandrini F, Figueiredo B, et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A. 2001;98:9330–9335.
   PubMed Web of Science ®Google Scholar
• Faria AM, Almeida MQ. Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults. Mol Cell Endocrinol. 2012;351:52–57.
   PubMed Web of Science ®Google Scholar
• Sandrini R, Ribeiro RC, DeLacerda L. Childhood adrenocortical tumors. J Clin Endocrinol Metab. 1997;82:2027–2031.
   PubMed Web of Science ®Google Scholar
• Hanna AM, Pham TH, Askegard-Giesmann JR, et al. Outcome of adrenocortical tumors in children. J Pediatr Surg. 2008;43:843–849.
   PubMed Web of Science ®Google Scholar
• Michalkiewicz E, Sandrini R, Figueiredo B, et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol. 2004;22:838–845.
   PubMed Web of Science ®Google Scholar
• Pianovski MA, Maluf EM, de Carvalho DS, et al. Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil. Pediatr Blood Cancer. 2006;47:56–60.
   PubMed Web of Science ®Google Scholar
• Weiss LM, Medeiros LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol. 1989;13:202–206.
   PubMed Web of Science ®Google Scholar
• Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655–663.
   PubMed Web of Science ®Google Scholar
• Ribeiro RC, Sandrini Neto RS, Schell MJ, et al. Adrenocortical carcinoma in children: a study of 40 cases. J Clin Oncol. 1990;8:67–74.
   PubMed Web of Science ®Google Scholar
• Bugg MF, Ribeiro RC, Roberson PK, et al. Correlation of pathologic features with clinical outcome in pediatric adrenocortical neoplasia. A study of a Brazilian population. Brazilian Group for Treatment of Childhood Adrenocortical Tumors. Am J Clin Pathol. 1994;101:625–629.
   PubMed Web of Science ®Google Scholar
• Cagle PT, Hough AJ, Pysher TJ, et al. Comparison of adrenal cortical tumors in children and adults. Cancer. 1986;57:2235–2237.
   PubMed Web of Science ®Google Scholar
• Mendonça BB, Lucon AM, Menezes CA, et al. Clinical, hormonal and pathological findings in a comparative study of adrenocortical neoplasms in childhood and adulthood. J Urol. 1995;154:2004–2009.
   Google Scholar
• Macfarlane DA. Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases. Ann R Coll Surg Engl. 1958;23:155–186.
   PubMedGoogle Scholar
• Wieneke JA, Thompson LD, Heffess CS. Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. Am J Surg Pathol. 2003;27:867–881.
   PubMed Web of Science ®Google Scholar
• Gulack BC, Rialon KL, Englum BR, et al. Factors associated with survival in pediatric adrenocortical carcinoma: an analysis of the National Cancer Data Base (NCDB). J Pediatr Surg. 2016;51:172–177.
   PubMed Web of Science ®Google Scholar
• Sabbaga CC, Avilla SG, Schulz C, et al. Adrenocortical carcinoma in children: clinical aspects and prognosis. J Pediatr Surg. 1993;28:841–843.
   PubMed Web of Science ®Google Scholar
• Sbragia L, Oliveira-Filho AG, Vassallo J, et al. Adrenocortical tumors in Brazilian children: immunohistochemical markers and prognostic factors. Arch Pathol Lab Med. 2005;129:1127–1131.
   PubMed Web of Science ®Google Scholar
• Dall'Igna P, Virgone C, De Salvo GL, et al. Adrenocortical tumors in Italian children: analysis of clinical characteristics and P53 status. Data from the national registries. J Pediatr Surg. 2014;49:1367–1371.
   PubMed Web of Science ®Google Scholar
• Teinturier C, Pauchard MS, Brugieres L, et al. Clinical and prognostic aspects of adrenocortical neoplasms in childhood. Med Pediatr Oncol. 1999;32:106–111.
   PubMedGoogle Scholar
• Icard P, Goudet P, Charpenay C, et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg. 2001;25:891–897.
   PubMed Web of Science ®Google Scholar
• Fassnacht M, Johanssen S, Quinkler M, et al. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer. 2009;115:243–250.
   PubMed Web of Science ®Google Scholar
• Lughezzani G, Sun M, Perrotte P, et al. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation. Eur J Cancer. 2010;46:713–719.
   PubMed Web of Science ®Google Scholar
• Hubertus J, Boxberger N, Redlich A, et al. Surgical aspects in the treatment of adrenocortical carcinomas in children: data of the GPOH-MET 97 trial. Klin Padiatr. 2012;224:143–147.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Galindo C, Figueiredo BC, Zambetti GP, et al. Biology, clinical characteristics, and management of adrenocortical tumors in children. Pediatr Blood Cancer. 2005;45:265–273.
   PubMed Web of Science ®Google Scholar
• Redlich A, Boxberger N, Strugala D, et al. Systemic treatment of adrenocortical carcinoma in children: data from the German GPOH-MET 97 trial. Klin Padiatr. 2012;224:366–371.
   PubMed Web of Science ®Google Scholar
• Ribeiro RC, Pinto EM, Zambetti GP, et al. The International Pediatric Adrenocortical Tumor Registry initiative: contributions to clinical, biological, and treatment advances in pediatric adrenocortical tumors. Mol Cell Endocrinol. 2012;351:37–43.
   PubMed Web of Science ®Google Scholar
• Terzolo M, Angeli A, Fassnacht M, et al. Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med. 2007;356:2372–2380.
   PubMed Web of Science ®Google Scholar
• Terzolo M, Ardito A, Zaggia B, et al. Management of adjuvant mitotane therapy following resection of adrenal cancer. Endocrine. 2012;42:521–525.
   PubMed Web of Science ®Google Scholar